Literature DB >> 20149183

The potential of genetically-modified pig mesenchymal stromal cells in xenotransplantation.

Mohamed Ezzelarab1, David Ayares, David K C Cooper.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 20149183      PMCID： PMC2835624          DOI： 10.1111/j.1399-3089.2009.00567.x

Source DB:  PubMed          Journal:  Xenotransplantation        ISSN： 0908-665X            Impact factor:   3.907


× No keyword cloud information.
  12 in total

1.  Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells.

Authors:  Katarina Le Blanc; Ida Rasmusson; Berit Sundberg; Cecilia Götherström; Moustapha Hassan; Mehmet Uzunel; Olle Ringdén
Journal:  Lancet       Date:  2004-05-01       Impact factor: 79.321

2.  Two steps to functional mesenchymal stromal cells for clinical application.

Authors:  Christina Bartmann; Eva Rohde; Katharina Schallmoser; Peter Pürstner; Gerhard Lanzer; Werner Linkesch; Dirk Strunk
Journal:  Transfusion       Date:  2007-08       Impact factor: 3.157

3.  Mesenchymal stem cell homing capacity.

Authors:  Valeria Sordi
Journal:  Transplantation       Date:  2009-05-15       Impact factor: 4.939

Review 4.  Mesenchymal stem cells can affect solid organ allograft survival.

Authors:  Felix C Popp; Elke Eggenhofer; Philipp Renner; Edward K Geissler; Pompiliu Piso; Hans J Schlitt; Marc H Dahlke
Journal:  Transplantation       Date:  2009-05-15       Impact factor: 4.939

5.  Marginal mass islet transplantation with autologous mesenchymal stem cells promotes long-term islet allograft survival and sustained normoglycemia.

Authors:  Mario G Solari; Suganya Srinivasan; Imene Boumaza; Jignesh Unadkat; George Harb; Adolfo Garcia-Ocana; Maryam Feili-Hariri
Journal:  J Autoimmun       Date:  2009-02-12       Impact factor: 7.094

6.  Muscular dystrophy therapy by nonautologous mesenchymal stem cells: muscle regeneration without immunosuppression and inflammation.

Authors:  Arsalan Shabbir; David Zisa; Merced Leiker; Curtis Johnston; Huey Lin; Techung Lee
Journal:  Transplantation       Date:  2009-05-15       Impact factor: 4.939

7.  Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study.

Authors:  Katarina Le Blanc; Francesco Frassoni; Lynne Ball; Franco Locatelli; Helene Roelofs; Ian Lewis; Edoardo Lanino; Berit Sundberg; Maria Ester Bernardo; Mats Remberger; Giorgio Dini; R Maarten Egeler; Andrea Bacigalupo; Willem Fibbe; Olle Ringdén
Journal:  Lancet       Date:  2008-05-10       Impact factor: 79.321

8.  Human islet-derived precursor cells are mesenchymal stromal cells that differentiate and mature to hormone-expressing cells in vivo.

Authors:  Behrous Davani; Laertis Ikonomou; Bruce M Raaka; Elizabeth Geras-Raaka; Russell A Morton; Bernice Marcus-Samuels; Marvin C Gershengorn
Journal:  Stem Cells       Date:  2007-09-27       Impact factor: 6.277

9.  Transplantation of human mesenchymal stems cells into intervertebral discs in a xenogeneic porcine model.

Authors:  Helena B Henriksson; Teresia Svanvik; Marianne Jonsson; Margret Hagman; Michael Horn; Anders Lindahl; Helena Brisby
Journal:  Spine (Phila Pa 1976)       Date:  2009-01-15       Impact factor: 3.468

Review 10.  Immunomodulation by mesenchymal stem cells: a potential therapeutic strategy for type 1 diabetes.

Authors:  Reza Abdi; Paolo Fiorina; Chaker N Adra; Mark Atkinson; Mohamed H Sayegh
Journal:  Diabetes       Date:  2008-07       Impact factor: 9.461
View more
  6 in total

1.  Adipose-derived mesenchymal stromal cells from genetically modified pigs: immunogenicity and immune modulatory properties.

Authors:  Goutham Kumar; Hidetaka Hara; Cassandra Long; Humza Shaikh; David Ayares; David K C Cooper; Mohamed Ezzelarab
Journal:  Cytotherapy       Date:  2012-01-23       Impact factor: 5.414

Review 2.  Do mesenchymal stem cells function across species barriers? Relevance for xenotransplantation.

Authors:  Jiang Li; Mohamed B Ezzelarab; David K C Cooper
Journal:  Xenotransplantation       Date:  2012 Sep-Oct       Impact factor: 3.907

Review 3.  Clinical lung xenotransplantation--what donor genetic modifications may be necessary?

Authors:  David K C Cooper; Burcin Ekser; Christopher Burlak; Mohamed Ezzelarab; Hidetaka Hara; Leela Paris; A Joseph Tector; Carol Phelps; Agnes M Azimzadeh; David Ayares; Simon C Robson; Richard N Pierson
Journal:  Xenotransplantation       Date:  2012 May-Jun       Impact factor: 3.907

Review 4.  Therapeutic issues in the treatment of vascularized xenotransplants using gal-knockout donors in nonhuman primates.

Authors:  Burcin Ekser; Goutham Kumar; Massimiliano Veroux; David K C Cooper
Journal:  Curr Opin Organ Transplant       Date:  2011-04       Impact factor: 2.640

5.  Human T cells upregulate CD69 after coculture with xenogeneic genetically-modified pig mesenchymal stromal cells.

Authors:  Jiang Li; Oleg Andreyev; Man Chen; Michael Marco; Hayato Iwase; Cassandra Long; David Ayares; Zhongyang Shen; David K C Cooper; Mohamed B Ezzelarab
Journal:  Cell Immunol       Date:  2013-08-29       Impact factor: 4.868

Review 6.  The potential role of genetically-modified pig mesenchymal stromal cells in xenotransplantation.

Authors:  Jiang Li; Mohamed B Ezzelarab; David Ayares; David K C Cooper
Journal:  Stem Cell Rev Rep       Date:  2014-02       Impact factor: 5.739
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.